產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-C9orf5抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-C9orf5抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-C9orf5
Cat. Number:
Anti-C9orf5抗體KL-15330R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
C9orf5 (chromosome 9 open reading frame 5), also known as CG2, is a 911 amino acid multi-pass membrane protein that is widely expressed and exists as four alternatively spliced isoforms. The gene encoding C9orf5 maps to human chromosome 9, which consists of about 145 million bases, representsAnti-C9orf5抗體 4% of the human genome and encodes nearly 900 genes. Considered to play a role in gender determination, deletion of the distal portion of 9p can lead to development of male to female sex reversal, the phenotype of a female with a male X,Y genotype. Hereditary hemorrhagic telangiectasia, which is characterized by harmful vascular defects, is associated with the chromosome 9 gene encoding endoglin protein, ENG. Familial dysautonomia is also associated with chromosome 9 though through the gene IKBKAP. Notably, chromosome 9 encompasses the largest interferon family gene cluster. Chromosome 9 is partnered with chromosome 22 in the translocation leading to the aberrant production of BCR-ABL fusion protein often found in leukemias.
Also known as:
C9orf5; TM245_HUMAN; Protein CG-2; Anti-C9orf5抗體Transmembrane protein C9orf5;
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Dog, Cow, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C9orf5.
●
Predicted Molecular Weight: 101kDa.
Storage:
Shipped at 4℃, Store at -20℃Anti-C9orf5抗體 (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions mustAnti-C9orf5抗體 be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions mustAnti-C9orf5抗體 be determined by the end user.
kl143Hu01 CD24分子(CD24)多克隆抗體 Polyclonal Antibody to Cluster Of Differentiation 24 (CD24)
kl144Hu01 唾液酸結(jié)合Ig樣凝集素2(SIGLEC2)多克隆抗體 Polyclonal Antibody to Sialic Acid Binding Ig Like Lectin 2 (SIGLEC2)
kl151Hu01 磷脂酶A1(PLA1)多克隆抗體 Polyclonal Antibody to Phospholikle A1 (PLA1)
kl154Hu01 纖維蛋白原α(FGα)多克隆抗體 Polyclonal Antibody to Fibrinogen Alpha (FGa)
kl154Mu01 纖維蛋白原α(FGα)多克隆抗體 Polyclonal Antibody to Fibrinogen Alpha (FGa)
kl154Ra01 纖維蛋白原α(FGα)多克隆抗體 Polyclonal Antibody to Fibrinogen Alpha (FGa)
kl160Hu01 抗增生抗體靶分子1(TAPA1)多克隆抗體 Polyclonal Antibody to Target Of The Antiproliferative Antibody 1 (TAPA1)
kl162Hu01 硫氧還蛋白結(jié)合蛋白2(TBP2)多克隆抗體 Polyclonal Antibody to Thioredoxin Binding Protein 2 (TBP2)
kl162Mu01 硫氧還蛋白結(jié)合蛋白2(TBP2)多克隆抗體 Polyclonal Antibody to Thioredoxin Binding Protein 2 (TBP2)
kl163Hu01 磷脂爬行酶2(PLSCR2)多克隆抗體 Polyclonal Antibody to Phospholipid Scramblase 2 (PLSCR2)
kl164Hu01 發(fā)動(dòng)蛋白2(DNM2)多克隆抗體 Polyclonal Antibody to Dynamin 2 (DNM2)
kl166Hu01 VGF神經(jīng)生長(zhǎng)因子誘導(dǎo)蛋白(VGF)多克隆抗體 Polyclonal Antibody to VGF Nerve Growth Factor Inducible (VGF)
kl166Mu01 VGF神經(jīng)生長(zhǎng)因子誘導(dǎo)蛋白(VGF)多克隆抗體 Polyclonal Antibody to VGF Nerve Growth Factor Inducible (VGF)
kl166Ra01 VGF神經(jīng)生長(zhǎng)因子誘導(dǎo)蛋白(VGF)多克隆抗體 Polyclonal Antibody to VGF Nerve Growth Factor Inducible (VGF)
kl167Hu01 CD4分子(CD4)多克隆抗體 Polyclonal Antibody to Cluster Of Differentiation 4 (CD4)
kl171Hu01 轉(zhuǎn)鐵蛋白受體(TFR)多克隆抗體 Polyclonal Antibody to Transferrin Receptor (TFR)
kl171Ra01 轉(zhuǎn)鐵蛋白受體(TFR)多克隆抗體 Polyclonal Antibody to Transferrin Receptor (TFR)
kl179Hu01 白介素31(IL31)多克隆抗體 Polyclonal Antibody to Interleukin 31 (IL31)
